Traitement des troubles associés au TND alpha
- 专利权人:
- ABBVIE BIOTECHNOLOGY LTD
- 发明人:
- 申请号：
- EP07150442.7
- 公开号：
- EP1944322B1
- 申请日:
- 2003.07.18
- 申请国别(地区):
- EP
- 年份:
- 2015
- 代理人:
- 摘要：
- Methods of treating TNFalpha-related disorders comprising administering TNFalpha inhibitors, including TNFalpha antibodies are described.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Method of Regulating Tumor Necrosis Factor-alpha (TNF-alpha) for Treating Cancers, Autoimmune Disorders, and Other Disorders Associated with Chronic Inflammation
- Expansion of Tumor Infiltrating Lymphocytes (TIL) with Tumor Necrosis Factor Receptor Superfamily (TNFRSF) Agonists and Treatment Combinations of TILs and TNFRSF Agonists
- Expansion culture of tumor infiltrating lymphocytes (TIL) by tumor necrosis factor receptor superfamily (TNFRSF) agonist and therapeutic combination of TIL and TNFRSF agonist
- Humanized anti-OX40 antibodies and uses thereof
- EXPANSION DE LYMPHOCYTES INFILTRANT LES TUMEURS (TIL) AVEC DES AGONISTES DE LA SUPERFAMILLE DES RECEPTEURS DU FACTEUR DE NECROSE TUMORALE (TNFRSF) ET DES COMBINAISONS THERAPEUTIQUES DE TIL ET D'AGONISTES DE TNFRSF
